Download PDF
Horm Metab Res 2022; 54(06): 396-406
DOI: 10.1055/a-1825-0316
Original Article: Endocrine Care

Investigation of the Relationship Between Autoimmune and Nodular Goiter in Patients with Euthyroid Polycystic Ovary Syndrome and Their Phenotypes

Seher Çetinkaya Altuntaş 
1   Division of Endocrinology, Bursa Yuksek Ihtisas Education and Training Hospital, University of Health Sciences, Bursa, Turkey
,
Mutlu Güneş
2   Department of Endocrinology and Metabolism, Bursa Yuksek Ihtisas Education and Training Hospital, University of Health Sciences, Bursa, Turkey
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Polycystic ovary syndrome (PCOS) is an endocrine disorder that frequently affects women of reproductive age. In PCOS, the incidence of thyroid diseases has increased in addition to reproductive and metabolic problems. To compare thyroid nodule, volume, autoimmunity, and thyroid function tests of euthyroid PCOS and its phenotypes. The files of 178 patients with PCOS aged 18–45 years and 92 patients with no disease who were matched for body mass index were retrospectively scanned. Women with PCOS were divided into four phenotypes, ABCD. Anti-TPO titer and prevalence, fT3, and thyroid volume were higher in the PCOS group compared with the control group in terms of anti-Tg levels, presence of nodules, and the number of nodules. There was no statistical difference between the PCOS group and the healthy controls. The number of nodules of 1 cm and above was found to be higher only in patients with PCOS compared with the control group. When the phenotypes were examined, thyroid dysfunction features were found in phenotype A, which was the most prominent. Thyroid autoimmunity, thyroid volume, and the number of nodules larger than 1 cm increased in patients with PCOS compared with controls. This situation is thought to be caused by the reproductive and metabolic properties of PCOS because thyroid dysfunction was detected more in phenotype A, which is called the full phenotype. Therefore, all patients with PCOS, especially phenotype A, should be evaluated for the presence of nodules with autoimmunity using USG, even if there are no symptoms, and thyroid functions.

Key words

polycystic ovary syndrome - PCO syndrome - phenotype - thyroid volume - thyroid autoimmunity - nodule


Publication History

Received: 14 February 2022

Accepted after revision: 13 April 2022

Accepted Manuscript online:
13 April 2022

Article published online:
13 June 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 March WA, Moore VM, Willson KJ. et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25: 544-551
    Google Scholar
  • 2 Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group.. REA-SPcw. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41-47
    CrossrefPubMedGoogle Scholar
  • 3 Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25
    CrossrefPubMedGoogle Scholar
  • 4 Spritzer PM, Lecke SB, Satler F. et al. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction 2015; 149: R219-R227
    CrossrefPubMedGoogle Scholar
  • 5 Sen A, Kushnir VA, Barad DH. et al. Endocrine autoimmune diseases and female infertility. Nat Rev Endocrinol 2014; 10: 37-50
    CrossrefPubMedGoogle Scholar
  • 6 Van Gelderen CJ, Gomes dos Santos ML. Polycystic ovarian syndrome. Evidence for an autoimmune mechanism in some cases. J Reprod Med 1993; 38: 381-386
    PubMedGoogle Scholar
  • 7 Petrikova J, Lazurova I. Ovarian failure and polycystic ovary syndrome. Autoimmun Rev 2012; 11: A471-A478
    CrossrefPubMedGoogle Scholar
  • 8 Hefler-Frischmuth K, Walch K, Huebl W. et al. Serologic markers of autoimmunity in women with polycystic ovary syndrome. Fertil Steril 2010; 93: 2291-2294
    CrossrefPubMedGoogle Scholar
  • 9 Antonelli A, Ferrari SM, Corrado A. et al. Autoimmune thyroid disorders. Autoimmun Rev 2015; 14: 174-180
    CrossrefPubMedGoogle Scholar
  • 10 Cooper DS. Clinical practice. Subclinical hypothyroidism. N Eng J Med 200; 345: 260–265
    PubMed
  • 11 Burguera B, Gharib H. Thyroid incidentelomas: prevalence, diagnosis, significance, and management. Endocrinol Metab Clin North Am 2000; 29: 187-203
    PubMedGoogle Scholar
  • 12 Duran C, Basaran M, Kutlu O. et al. Frequency of nodular goiter and autoimmune thyroid disease in patients with polycystic ovary syndrome. Endocrine. 2015; 49: 464-469
    CrossrefPubMedGoogle Scholar
  • 13 Anaforoglu I, Topbas M, Algun E. Relative associations of polycystic ovarian syndrome vs metabolic syndrome with thyroid function, volume, nodularity and autoimmunity. J Endocrinol Invest 2011; 34: e259-e264
    PubMedGoogle Scholar
  • 14 Danfeng D, Xuelian L. The relationship between thyroiditis and polycystic ovary syndrome: a meta-analysis. Int J Clin Exp Med 2013; 6: 880-889
    PubMedGoogle Scholar
  • 15 Arduc A, Aycicek Dogan B, Bilmez S. et al. High prevalence of Hashimoto’s thyroiditis in patients with polycystic ovary syndrome: does the imbalance between estradiol and progesterone play a role?. Endocr Res 2015; 40: 204-210
    CrossrefPubMedGoogle Scholar
  • 16 Sinha U, Sinharay K, Saha S. et al. Thyroid disorders in polycystic ovarian syndrome subjects: a tertiary hospital based cross-sectional study from Eastern India. Indian J Endocrinol Metab 2013; 17: 304-309
    CrossrefPubMedGoogle Scholar
  • 17 Nils K, Peter L, Hans P. et al. Risk factors for goiter and thyroid nodule. Thyroid 2002; 12: 879-888
    CrossrefPubMedGoogle Scholar
  • 18 Garelli S, Masiero S, Plebani M. et al. High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2013; 169: 248-251
    CrossrefPubMedGoogle Scholar
  • 19 Janssen OE, Mehlmauer N, Hahn S. et al. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol 2004; 150: 363-369
    CrossrefPubMedGoogle Scholar
  • 20 Ganie MA, Marwaha RK, Aggarwal R. et al. High prevalence of polycystic ovary syndrome characteristics in girls with euthyroid chronic lymphocytic thyroiditis: a case-control study. Eur J Endocrinol 2010; 162: 1117-1122
    CrossrefPubMedGoogle Scholar
  • 21 Kachuei M, Jafari F, Kachuei A. et al. Prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Arch Gynecol Obstet 2012; 285: 853-856
    CrossrefPubMedGoogle Scholar
  • 22 Romitti M, Fabris VC, Ziegelmann PK. et al. Association between PCOS and autoimmune thyroid disease: a systematic review and meta-analysis. Endocr Connect 2018; 7: 1158-1167
    CrossrefPubMedGoogle Scholar
  • 23 Carle A, Laurberg P, Knudsen N. et al. Thyroid peroxidase and thyroglobulin auto-antibodies in patients with newly diagnosed overt hypothyroidism. Autoimmunity 2006; 39: 497-503
    CrossrefPubMedGoogle Scholar
  • 24 Gaberscek S, Zaletel K, Schwetz V. et al. Mechanisms in endocrinology: thyroid and polycystic ovary syndrome. Eur J Endocrinol 2015; 172: R9-R21
    CrossrefPubMedGoogle Scholar
  • 25 Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocrine Reviews 2010; 31: 702-755
    CrossrefPubMedGoogle Scholar
  • 26 Klecha AJ, Barreiro Arcos ML, Frick L. etal. Immune-endocrine interactions inautoimmune thyroid diseases. Neuroimmunomodulation 2008; 15: 68-75
    CrossrefPubMedGoogle Scholar
  • 27 Quintero OL, Amador-Patarroyo MJ, Montoya-Ortiz G. et al. Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun 2012; 38: J109-J119
    CrossrefPubMedGoogle Scholar
  • 28 Petrikova J, Lazurova I, Yehuda S. Polycystic ovary syndrome and autoimmunity. Eur J Intern Med 2010; 21: 369-371
    CrossrefPubMedGoogle Scholar
  • 29 Hughes GC. Progesterone and autoimmune disease. Autoimmun Rev 2012; 11: A502-A514
    CrossrefPubMedGoogle Scholar
  • 30 Erdoğan G, Erdoğan MF, Delange F. et al. Moderate to severe iodine deficiency in three endemic goitre areas from the Black Sea region and the capital of Turkey. Eur J Epidemiol 2000; 16: 1131-1134
    CrossrefPubMedGoogle Scholar
  • 31 Emral R, Baştemir M, Güllü S. et al. Thyroid consequences of the Chernobyl nuclear power station accident on the Turkish population. Eur J Endocrinol 2003; 148: 497-503
    CrossrefPubMedGoogle Scholar
  • 32 Anil C, Akkurt A, Ayturk S. et al. Impaired glucose metabolism is a risk factor for increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Metabolism 2013; 62: 970-975
    CrossrefPubMedGoogle Scholar
  • 33 Rezzonico J, Rezzonico M, Pusiol E. et al. Introducing the Thyroid Gland as Another Victim of the Insulin Resistance Syndrome. Thyroid 2008; 18: 461-464
    CrossrefPubMedGoogle Scholar
  • 34 Ayturk S, Gursoy A, Kut A. et al. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur J Endocrinol 2009; 161: 599-605
    CrossrefPubMedGoogle Scholar
  • 35 Junik R, Kozinski M, Debska-Kozinska K. Thyroid ultrasound in diabetic patients without overt thyroid disease. Acta Radiol 2006; 47: 687-691
    CrossrefPubMedGoogle Scholar
  • 36 Tode B, Serio M, Rotella CM. et al. Insulin-like growth factor -1 autocrine secretion by human thyroid follicular cells in primary culture. J Clin Endocrinol Metal 1989; 69: 639-647
    CrossrefPubMedGoogle Scholar
  • 37 Pothiwala P, Jain SK, Yaturu S. Metabolic syndrome and cancer. Metab Syndr Relat Disord 2009; 7: 279-288
    CrossrefPubMedGoogle Scholar
  • 38 De Pergola G, Giorgino F, Benigno R. et al. Independent influence of insulin, catecholamines, and thyroid hormones on metabolic syndrome. Obesity (Silver Spring) 2008; 16: 2405-2411
    CrossrefPubMedGoogle Scholar
  • 39 Moran L, Teede H. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod Update 2009; 15: 477-488
    CrossrefPubMedGoogle Scholar